Arrowhead Pharma (ARWR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 12-2000 | 09-2000 | 06-2000 | 03-2000 | 12-1999 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -41 | -130 | -172 | -115 | -60 |
| Depreciation Amortization | 2 | 8 | 6 | 4 | 2 |
| Accounts receivable | -1 | 9 | 10 | 10 | N/A |
| Accounts payable and accrued liabilities | -12 | -1 | 2 | 44 | N/A |
| Other Working Capital | 20 | 40 | 107 | 113 | 50 |
| Other Operating Activity | 13 | -6 | -12 | -54 | 10 |
| Operating Cash Flow | $-19 | $-80 | $-59 | $2 | $2 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -1 | -1 | -1 | -1 |
| Investing Cash Flow | $N/A | $-1 | $-1 | $-1 | $-1 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -1 | -2 | -2 | -1 | N/A |
| Other Financing Activity | 18 | 82 | 62 | 0 | -1 |
| Financing Cash Flow | $17 | $80 | $60 | $-1 | $-1 |
| Beginning Cash Position | 2 | N/A | 0 | 0 | 0 |
| End Cash Position | 0 | 2 | 1 | 1 | 0 |
| Net Cash Flow | $-2 | $2 | $0 | $1 | $0 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19 | -80 | -59 | 2 | 2 |
| Capital Expenditure | N/A | -1 | -1 | -1 | N/A |
| Free Cash Flow | -19 | -81 | -60 | 2 | 2 |